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Aims and Methods To examine whether national initiatives have led to
improvements in the physical health of people with psychosis. Secondary analysis of
a national audit of services for people with psychosis. Proportions of patients in ‘good
health’ according to seven measures, and one composite measure derived from
national standards, were compared between multiple rounds of data collection.
Results The proportion of patients in overall ‘good health’ under the care of ‘Early
Intervention in Psychosis’ teams increased from 2014–2019, particularly for
measures of smoking, alcohol and substance use. There was no overall change in the
proportion of patients in overall ‘good health’ under the care of ‘Community Mental
Health Teams’ from 2011–2017. However, there were improvements in alcohol use,
blood glucose and lipid levels.
Clinical implications There have been modest improvements in the health of
people with psychosis over the last nine years. Continuing efforts are required to
translate these improvements into reductions in premature mortality.
Keywords Physical health; psychosis; schizophrenia; community mental health
teams; early intervention.
Concerns have repeatedly been raised regarding premature
mortality among people with schizophrenia and other psych-
otic disorders.1–6 People who experience psychosis die on
average 10–20 years earlier than the general population.7,8
Factors contributing to this inequality may include eco-
nomic disadvantage, health risk behaviours and difficulties
accessing and adhering to medical treatments.9–11 These
frequently translate to poor physical health, and psychotic
disorders are strongly associated with unfavourable out-
comes for a range of physical health measures: smoking sta-
tus, weight, serum glucose levels, blood pressure and serum
lipids.12,13 These issues can be compounded by metabolic
side-effects of antipsychotic medication,14–17 and an
increased risk of cardiovascular disease is widely accepted
as the primary mediator of reduced life expectancy.4,18–20
National initiatives
In 2014, the National Institute for Health and Care
Excellence (NICE) produced recommendations to guide
screening and intervention for common physical health pro-
blems experienced by people with psychosis.21 The same
year, NHS England announced a new Commissioning for
Quality and Innovation (CQUIN) framework, providing
financial incentives for physical health screening and inter-
ventions within secondary mental health services.22 The
‘Positive Cardiometabolic Health Resource’ was published,
with support from the Royal Colleges of Psychiatrists,
Physicians, Nursing and General Practice, establishing a
user-friendly manual for clinicians providing care to patients
with severe mental illness.23
Since these initiatives were implemented, there is some
evidence that the quality of physical healthcare delivered to
patients with psychosis has improved.24 However, there are
ongoing concerns that this has not translated to an improve-
ment in patients’ health. A recent study found that cardiometa-
bolic risk factors were already pronounced in those presenting
to services with a first episode of psychotic illness, and that
physical health deteriorated during thefirst year of treatment.25
In light of these apparent contradictions, we aimed to
investigate whether physical health has improved among
people with psychotic disorders. We conducted a secondary
analysis of data gathered over the past 9 years, during
national audits of services for people with psychosis.
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Method
All data for this study were collected during two audit
rounds conducted as part of the National Clinical Audit of
Psychosis (NCAP) by the Royal College of Psychiatrists.26
Both examined services providing care to people with psych-
otic disorders in England. A ‘core’ audit generated data on
people under the care of community mental health teams
(CMHTs), with three rounds of data collection in 2011,
2013 and 2017. A ‘spotlight’ audit collected additional data
on the quality of care received by people with first-episode
psychosis (FEP) who received care from early intervention
for psychosis (EIP) teams. Three rounds of the spotlight
audit were conducted in 2014, 2018 and 2019. All National
Health Service (NHS) Provider Trusts in England with
CMHTs and EIP teams that provided care to patients with
psychotic disorders were invited to take part in these
respective audits.
For both audits, all participating organisations were
asked to provide an anonymised list of eligible patients
who fulfilled inclusion criteria during a 12-month ‘sampling
window’ before the point of data collection. From each list,
100 patients were randomly selected for inclusion in the
audit. For the CMHT audit, patients were eligible for inclu-
sion if they had an active period of care with a participating
CMHT, were aged ≥18 years and had an established diagno-
sis of schizophrenia or schizoaffective disorder (ICD-10
codes F20/F25) recorded during the 12-month sampling
period. Patients were excluded if they had received
in-patient care or care from an EIP team during this period.
For the EIP audit, patients were eligible for inclusion if they
had an active period of care with a participating EIP team,
were aged ≥14 years and had a diagnosed ‘first episode’ of
any psychotic disorder (ICD-10 codes F20-F29) recorded
during the 12-month sampling period. For the purposes of
this study, we excluded any patients whose host organisation
did not participate in all three rounds of the respective audit.
For both audits, staff from each organisation were asked
to conduct a retrospective review of case notes from the
sampling window, and extract data to complete an online
data collection tool. The tool included questions on physical
health measures, quantifying patients’ smoking status, alco-
hol use, blood pressure, body mass index (BMI), serum glu-
cose, serum lipids and whether they were known to use illicit
substances. The data collection tools for both audits were
based on NICE guidance for management of psychotic disor-
ders.21 They were developed in collaboration with patients
and providers of psychiatric services, and carer representa-
tives with lived experience of supporting patients with
psychotic disorders. The tool was piloted by six volunteer
trusts before the main audit, to ensure that the process
was understandable and acceptable.
During the development of this project, the National
Research Ethics Service and the Ethics and Confidentiality
Committee of the National Information Governance Board
advised that formal ethical approval and individual partici-
pants’ informed consent were not required because this
was a secondary analysis of audit data and patient-
identifiable data were not being collected. The authors assert
that all procedures contributing to this work comply with
the ethical standards of the relevant national and
institutional committees on human experimentation and
with the Helsinki Declaration of 1975, as revised in 2008.
Exposure, outcome measures and covariates
The primary outcome measures for this study were whether
patients were considered to be in ‘good health’, according to
for seven discrete physical health measures and one compos-
ite measure. The seven measures of good health were smok-
ing status (not currently smoking, e.g. non-smoker or
ex-smoker), alcohol use (no recorded ‘harmful or hazardous’
alcohol use), illicit substance use (no recorded illicit sub-
stance use), blood pressure (normotensive, i.e. <140/90
mmHg), BMI (within normal range, i.e. 18.5–24.9), serum
glucose (within normal range, i.e. fasting blood glucose
<5.5 mmol/L and/or random plasma glucose <11.1 mmol/L
and/or hemoglobin A1C <42 mmol/mol) and serum lipids
(within normal range, i.e. total serum cholesterol <5.1
mmol/L and/or high-density lipoprotein >1 mmol/L and/or
non-high-density lipoprotein <4.1 mmol/L). The definition
of good health for each measure was based on the standards
implemented by the national Mental Health Commissioning
for Quality and Innovation analysis.22 To be considered in
good health for the composite measure, patients had to fulfil
the criteria for good health for all of the seven discrete
measures.
In addition, patients’ age and gender were recorded, to
provide demographic information about the overall sample
for each audit.
Statistical methods
We used SPSS (version 26 for Windows)27 to analyse the
study data. For each round of the audits, the proportion of
patients with good health were calculated for each of the
physical health measures and the composite measure. The
variation in these proportions between each round of the
two audits was then examined with binomial logistic
regression.
Variation in demographic characteristics (age and gen-
der) were compared between the CMHT and EIP audits,
using t- and χ2-tests, respectively.
For many patients, data were not recorded for some of
the physical health measures (presumably because it was
not available in the clinical records, possibly because of
patients refusing to undergo investigation or provide infor-
mation).28 Missing values were not included in the analysis.
Results
For the CMHT audit, 57 NHS Provider Trusts submitted
data for all three rounds. Data from 16 752 sets of case
notes were analysed (4618 from the first round in 2011,
4785 from the second round in 2013 and 7349 from the
third round in 2017). For the EIP audit, 54 NHS Provider
Trusts submitted data for all three rounds. Data from 20
611 sets of case notes were analysed (2158 from the first
round in 2014, 8768 from the second round in 2018 and
9685 from the third round in 2019).
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Table 1 summarises the demographic characteristics
(age and gender) for the total samples of the CMHT audit
and EIP audit, respectively. Across the three rounds,
patients in the CMHT audit were significantly older than
those in the EIP audit, with mean ages of 47.11 years and
29.66 years, respectively (t(37 361) = 156.94, P < 0.001). In
the CMHT audit, 65.6% of the total sample were men, com-
pared with 64.2% in the EIP audit, which was not a statistic-
ally significant difference.
Table 2 summarises the proportion of CMHT patients
in good health according to each of our outcome measures
(including the composite measure), and the variation in
these proportions over time across the three rounds of the
CMHT audit. There were variable amounts of missing data
for each of the seven outcome measures, meaning that the
composite measure could only be used for 31.3% (5243/
16 752) of CMHT patients.
There was some evidence of improvement in health.
CMHT patients in the third round were significantly more
likely than those in the first round to be in good health
according to measures of alcohol use (odds ratio 1.48, 95%
CI 1.31–1.67, P≤ 0.001), blood glucose levels (odds ratio
2.12, 95% CI 1.89–2.36, P < 0.001) and blood lipids (odds
ratio 1.78, 95% CI 1.60–1.98, P < 0.001).
However, CMHT patients in the third round were less
likely to be in good health for the illicit substance use meas-
ure (odds ratio 0.76, 95% CI 0.68–0.85, P < 0.001), i.e. a
higher proportion of CMHT patients were using illicit sub-
stances in 2017 compared with 2011. The proportion of
CMHT patients in overall good health according to the com-
posite measure was consistently low across all three rounds
of the audit, and decreased from 3.3% in 2011 to 2.7% in
2017, although this was not statistically significant.
Table 3 summarises the proportion of EIP patients in
good health according to each of our outcome measures
(and the composite measure), and the variation in these pro-
portions over time across the three rounds of the EIP audit.
Similarly, there were variable amounts of missing data for
each of the seven outcome measures, meaning that the com-
posite measure could only be used for 56.4% (11 625/20 611)
of EIP patients.
This audit also showed improvements in some of the
measures of health over time: notably, those relating to
smoking (odds ratio 1.22, 95% CI 1.11–1.35, P < 0.001),
alcohol use (odds ratio 1.43, 95% CI 1.23–1.68, P < 0.001)
and illicit substance use (odds ratio 1.86, 95% CI 1.68–2.07,
P < 0.001). Furthermore, the proportion of EIP patients
with overall good health was significantly higher in the
third round compared with the first (odds ratio 4.65, 95%
CI 3.32–6.52, P < 0.001), although this remained the minor-
ity (10.3%). Also, EIP patients in 2019 were significantly less
likely than those in 2014 to be in good health for the BMI
measure (odds ratio 0.69, 95% CI 0.60–0.79, P < 0.001).
Discussion
This study corroborates previous findings that the physical
health of people with psychosis remains poor, despite an
improvement in physical health screening and intervention
following national initiatives implemented in England
since 2014.24
Both CMHT and EIP audits showed improvements in
health according to some of these measures, and deteriora-
tions in others. The proportion of patients in overall good
health according to a composite measure was low across
all rounds of both audits, but did improve significantly
post-2014 for those patients receiving care from EIP
services.
Unhealthy weight remains a particular area of concern,
with large proportions of patients in poor health according
to BMI across all rounds of both audits, and a significant
deterioration over time in the EIP audit. This supports exist-
ing evidence that weight management is challenging for
patients with psychotic disorders.29,30
We did find some evidence of a modest improvement in
rates of smoking amongst patients under the care of EIP ser-
vices post-2014. This contradicts recent studies where
results have been more pessimistic,25,31 but would be in
line with previous research suggesting a change in the epi-
demiology of smoking, with a gradual reduction in smoking
in younger age groups.32 This improvement over time was
not reflected in the CMHT audit, where patients were on
average significantly older.
There was also a marked reduction post-2014 in the pro-
portion of patients under the care of EIP services who were
using illicit substances. This contrasted with the CMHT
audit where the proportion increased slightly over time.
Strengths and limitations
Data were obtained from large, heterogenous samples over a
9-year period: all NHS Trusts in England with CMHT and
EIP services that provided care to patients with psychotic
disorders were invited to participate in the respective audits.
These data therefore represent a variety of different settings,
and we would expect that results would be generalisable to
similar patient groups across the country. The primary out-
come measures we used to assess physical health are univer-
sally recognised as clinically important, and the thresholds
for good health were based on national standards that have
been widely used elsewhere.33–35
However, this study does have important limitations.
First, this is an observational study and we do not know
what caused the changes we observed. Although they may
Table 1 Demographic characteristics of people with psych-
osis in the CMHT and EIP audits
CMHT audit EIP audit
Age, mean (s.d.) 47.11 (±12.02) 29.66 (±9.47)
Difference in age between audits was statistically significant as
determined by t-test: t(37361) = 156.94, P < 0.001
Gender, n (%)
Male 10 989 (65.6) 13 232 (64.2)
Female 5763 (34.4) 7379 (35.8)
Difference in gender between audits was not statistically significant
as determined by χ2-test: χ2 = 1.23, P = 0.267
CMHT, community mental health team; EIP, early intervention in psychosis.
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reflect changes in services during this period, other changes
in society are affecting population health,36 and these could
be responsible for some or all the differences we detected.
The EIP and CMHT audits were conducted at different
times, both before and after the CQUIN framework was imple-
mented, and used different selection criteria. Differences in the
physical health of patients between the two are therefore likely
to reflect the differing clinical and socioeconomic demographic
characteristics of the patients in each audit, as well as different
processes of care.Wewere able to examine changes in physical
health over time within each audit, by comparing different
rounds. However, as each service provided a random sample
of eligible patients at each round, subsequent rounds of the
same audit did not necessarily include the same cohort, and
so we are unable to make inferences about changes in health
at the level of individual patients even within the same audit.
For both the EIP and CMHT audits, we were able to
examine physical health measures before and after the intro-
duction of the Commissioning for Quality and Innovation
programme.22 Although the introduction of the programme
was associated with a marked increase in the proportion of
patients who were offered interventions for their physical
health,24 we found only limited evidence that this resulted
in changes to the health of people under the care of CMHTs.
These data were produced from retrospective case note
audits at each round, and are therefore dependant on accur-
ate reporting and documentation of events at the time of
occurrence. Clinicians working in CMHTs and EIP services
may not have had full access to records held by primary
care, where some physical health screening may have
occurred.
Also, there were variable amounts of missing data for
each primary outcome measure, meaning that the composite
measure could only be used for a relatively small proportion
of the overall sample. However, the proportion of missing
data did generally improve over subsequent rounds of each
audit, possibly reflecting the previously noted incentivised
improvements in screening rates and recording.24
Implications
We found some evidence that overall health improved for
patients with psychotic disorders under the care of EIP ser-
vices between 2014 and 2019. However, we did not find
Table 2 Proportion of people with psychosis with good health outcomes at each round of the community mental health
team audit
2011 Audit 2013 Audit 2017 Audit
n/N n/N n/N
% % %
Odds ratio (95% CI), P-value Odds ratio (95% CI), P-value Odds ratio (95% CI), P-value
Smoking 1694/4016 1769/4286 2784/6342
42.2 41.3 43.9
Reference 0.97 (0.89–1.06), 0.566 1.07 (0.99–1.16), 0.090
Alcohol use 2691/3197 2887/3387 5686/6410
84.2 85.2 88.7
Reference 1.09 (0.95–1.24), 0.244 1.48 (1.31–1.67), <0.001
Illicit substance use 3377/3888 3699/4243 5281/6332
86.9 87.2 83.4
Reference 1.03 (0.90–1.17), 0.689 0.76 (0.68–0.85), <0.001
Body mass index 502/1202 571/2587 992/4537
22.8 22.1 21.9
Reference 0.96 (0.84–1.10), 0.572 0.95 (0.84–1.07), 0.406
Blood pressure 1900/2593 2191/2946 3642/4855
73.3 74.4 75.0
Reference 1.06 (0.94–1.19), 0.371 1.10 (0.98–1.22), 0.107
Blood glucose levels 1449/2297 1502/2690 3393/4332
63.1 55.8 78.3
Reference 0.74 (0.66–0.83), <0.001 2.12 (1.89–2.36), <0.001
Blood lipids 924/2186 1143/3002 2350/4152
42.3 42.3 56.6
Reference 1.00 (0.89–1.12), 0.998 1.78 (1.60–1.98), <0.001
Composite measure 33/1004 34/1372 76/2867
3.3 2.5 2.7
Reference 0.74 (0.46–1.22), 0.294 0.80 (0.53–1.21), 0.348
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evidence of a similar improvement for patients under the
care of CMHTs between 2011 and 2017.
This may reflect differences in the model of care imple-
mented by EIP services. Typically, these services advocate a
more ‘intensive’ programme of intervention, with a focus on
relatively smaller case-loads, proactive engagement and an
increased frequency of contact.35–39 Although this approach
is primarily intended to address psychiatric symptoms, mul-
tiple sources have suggested additional benefits for patients’
overall health, including increased levels of screening for
physical health problems.40 EIP services may, therefore,
have been better placed to implement changes resulting
from the national initiatives rolled out in 2014.
However, the difference may also be because of differ-
ences in demographic and clinical characteristics between
patients in the CMHT audit and the EIP audit. Patients in
the EIP audit were younger on average, and were also likely
to have had a shorter duration of psychiatric symptoms (as
this audit specifically examined patients with a diagnosed
‘first episode’ of a psychotic disorder). These patients may
have been more accepting of interventions intended to
improve their physical health and, therefore, have seen
greater improvements – even if CMHTs and EIP services
had implemented identical changes since 2014.
It may even be the case that people in younger age
groups have become more ‘health conscious’ in recent
years regardless of any intervention, as suggested by some
epidemiological studies.32 However, this seems unlikely in
these cohorts in light of previous findings that patients on
EIP case-loads already had pronounced cardiovascular risk
factors, even at the point of first presentation.25
Both audits identified some isolated areas of improve-
ment in specific measures. Interestingly, these differed
between the patients in the CMHT audit, where there
were improvements related to alcohol use, serum glucose
level and lipids, and the EIP audit, where there were
improvements in alcohol use, smoking and illicit substance
use. Again, these changes may relate to demographic differ-
ences in the patients under the care of these respective ser-
vices. Older patients may be more receptive to those that
they perceive as reducing their risk of major cardiovascular
events, such as reduction in serum glucose and lipids.
However, these varying improvements may also be
because of differences in the treatment approaches adopted
Table 3 Proportion of people with psychosis with good health outcomes at each round of the audit of early intervention in
psychosis services
2014 Audit 2018 Audit 2019 Audit
n/N n/N n/N
% % %
Odds ratio (95% CI), P-value Odds ratio (95% CI), P-value Odds ratio (95% CI), P-value
Smoking 885/1808 4015/7832 4581/8487
49.0 51.3 54.0
Reference 1.10 (0.99–1.22), 0.080 1.22 (1.11–1.35), <0.001
Alcohol use 1620/1853 7021/7774 7749/8526
87.4 90.3 90.9
Reference 1.34 (1.15–1.57), <0.001 1.43 (1.23–1.68), <0.001
Illicit substance use 1182/1905 5711/7831 6410/8517
62.1 72.9 75.3
Reference 1.65 (1.48–1.83), <0.001 1.86 (1.68–2.07), <0.001
Body mass index 460/1044 2314/6667 2662/7566
44.1 34.7 35.2
Reference 0.68 (0.59–0.77), <0.001 0.69 (0.60–0.79), <0.001
Blood pressure 924/1106 5513/6733 6314/7750
83.5 81.9 81.5
Reference 0.89 (0.75–1.06), 0.195 0.87 (0.73–1.03), 0.104
Blood glucose levels 721/803 5071/5525 6175/6733
89.8 91.8 91.7
Reference 1.27 (0.99–1.63), 0.068 1.26 (0.99–1.61), 0.075
Blood lipids 506/741 3546/5416 4265/6564
68.3 65.5 65.0
Reference 0.88 (0.75–1.04), 0.141 0.86 (0.73–1.01), 0.079
Composite measure 37/1543 422/4465 576/5617
2.4 9.5 10.3
Reference 4.25 (3.02–5.98), <0.001 4.65 (3.32–6.52), <0.001
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by CMHTs and EIP services. These findings merit further
research to identify the factors explaining these variations, as
well as the improvement in overall good health seen among
those treated by EIP services. There may be elements where
each service outperforms the other; for example, access to
staffwith training inphysical health interventions, or improved
links with primary care. Cohort or case–control studies could
beusedwithinCMHTsandEIP services to examinewhat inter-
ventions are associated with favourable physical health out-
comes at an individual patient level. Qualitative studies to
explore the perspectives of patients with psychosis may also
identify effective strategies for improving patients’ physical
health. It may also be of interest to include other services,
such as assertive outreach teams, in future studies.
The fact that the EIP audit showed an improvement in
rates of illicit substance use over time, but the CMHT audit
showed the opposite, is an intriguing finding and of unclear
significance. It does not seem to reflect the current under-
standing of the changing epidemiology of illicit substance
use,41 and suggests that EIP services have been able to
implement effective measures to support people in abstain-
ing from illicit substances.
Interestingly, the one measure where both CMHTs and
EIP services improved over time was alcohol use. Many drug
and alcohol services in the UK are now provided by third-
sector organisations rather than NHS mental health
teams.42,43 The fact that both CMHTs and EIP services
were able to effect improvement suggests that effective
liaison with external organisations may be a key strategy
for improvement, rather than attempting to deliver more
services with internal infrastructure, which may already be
overstretched.
Both audits showed specific areas where standards of
physical health worsened over time. The findings related to
patients’ weight are particularly concerning: the proportion
of patients with a healthy BMI fell significantly across the
three rounds of the EIP audit, and was universally low in
the CMHT audit. Weight gain is a well-recognised and par-
ticular troubling side-effect of many antipsychotic medica-
tions.17 Given the implications of obesity for subjective
well-being, medication adherence and therapeutic outcomes
in the context of treatment for psychosis, and associated dia-
betes and cardiovascular risk and likelihood of premature
mortality,44–46 improving interventions in this area needs
to remain a focus for researchers. To date, studies of current
weight management programmes for people with psychosis
have produced mixed results.47–49
In addition to these findings, it is also important to note
that the majority of patients did not have adequate informa-
tion recorded for all seven of the physical health measures
recommended by nationally agreed standards. Only around
half of patients in the EIP audit, and a third of those in
the CMHT audit, had usable data recorded for all seven mea-
sures. The reasons for this are unclear from this project, and
may reflect barriers to physical health screening, such as
refusal, lack of provision or inadequate documentation.
Clearly, accurate monitoring is required, and will be the
focus of quality improvement activities before future rounds
of the national audits.
In conclusion, we found limited evidence that overall
health improved for patients with psychotic disorders
under the care of CMHTs, following the enactment of
national initiatives in 2014, although there was some evi-
dence of improvement in specific areas. There was more sub-
stantial evidence of improvements for those patients under
the care of EIP services. This may be a result of differences
in CMHT and EIP services’ abilities to implement effective
changes in policy and procedures, or demographic and clin-
ical differences in their respective patients. However, these
findings merit further research into the processes under-
lying the improvements in health, to improve the standard
of care for people with psychosis.
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